Status:
COMPLETED
Mifepristone Versus Laminaria Insertion for Cervical Preparation Prior to Surgical Abortion at 14-16 Weeks
Lead Sponsor:
Boston University
Collaborating Sponsors:
Society of Family Planning
Conditions:
Abortion
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
Women who are requesting pregnancy termination at 14-16 weeks, who would normally have osmotic dilator insertion the day before their procedure, would be asked if they wanted to participate. Participa...
Eligibility Criteria
Inclusion
- women aged 18-45 having pregnancy termination at 14-16 weeks
Exclusion
- multiple gestation, pre-existing infection, contraindication to osmotic dilators, unable to obtain proper consent
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2011
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00986921
Start Date
October 1 2009
End Date
March 1 2011
Last Update
January 31 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Medical Center
Boston, Massachusetts, United States, 02118